Email Updates

Search form

You are here

AIDS Vaccines

There is momentum and promise in the search for an AIDS vaccine.

An effective preventive AIDS vaccine would teach the body how to prevent HIV infection. Vaccines are the most powerful public health tools available—and an AIDS vaccine would play a powerful role in ensuring the end to the AIDS epidemic.

While effective vaccines remain years away, there are more reasons for hope than ever before. Researchers are expanding on the result of a 2009 trial that showed, for the first time, that a vaccine can reduce the risk of HIV infection. They’re also pursuing groundbreaking research with other novel vaccine strategies, including broadly neutralizing antibodies that target a wide range of HIV strains. At the same time, there is also exciting work in efforts to understand if and how to cure HIV in people who are already infected. The timeline for this work is long and uncertain. Here, too, advocacy is needed to sustain momentum.

Today’s momentum depends on sustained funding. Policy makers and funders around the world must have the courage to sustain vital AIDS vaccine research for years to come, and advocates must keep the pressure on them to maintain their commitments.

What We're Reading

A comprehensive scientific review of the biology of one of the immune responses thought to be critical to an effective AIDS vaccine with graphics that help illustrate key aspects of broadly-neutralizing antibodies.

June 23, 2015

On June 17-18, a network of journalists from Zimbabwe, Malawi and Zambia met during an HIV Vaccines Regional Symposium in Lusaka to discuss the media’s role in reporting on HIV vaccines. The network also met with researchers and activists who discussed the importance of accelerating the development of an AIDS vaccine.

June 20, 2015
All Africa

Southern African researchers and HIV and AIDS advocates have called on governments to consider investing in HIV vaccine trials.

June 19, 2015
The Daily Times

New studies demonstrate that the immune system can be accelerated so it’s primed and ready to block HIV infection. The strategy trains the immune system to make the desired antibodies with increasingly greater potency. When the body is confronted with HIV, it can repel the infection.

June 18, 2015
The San Diego Union-Tribune
Subscribe to RSS - AIDS Vaccines